News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
TEPPER ROBERT I
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 100,000 shares
@ $9.27, valued at
$927k
Sold 50,000 shares
@ $9.22, valued at
$461k
|
|
| 01/24/2023 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 100,000 shares
@ $9.15, valued at
$915k
Sold 55,000 shares
@ $9.06, valued at
$498.3k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2022 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
| 08/26/2022 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 149,972 shares
@ $6.09, valued at
$913.3k
Sold 200,000 shares
@ $6.22, valued at
$1.2M
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 1,900,000 shares
@ $8.38, valued at
$15.9M
|
|
| 11/12/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 11/23/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $7.005, valued at
$105.1k
|
|
| 11/19/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $7.2515, valued at
$108.8k
|
|
| 11/13/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 09/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| TEPPER ROBERT I (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.58, valued at
$102.7k
|
|
|
|
|